Doctor profile · Federal record
Dr. VAHID MAHABADI, MD, MPH
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · SYLMAR, CA
- NPI 1144412453
- Accepts Medicare
- 31 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
14445 OLIVE VIEW DR DEPT OF
SYLMAR, CA 913421437
(818) 364-3205 - Mailing address
-
PO BOX 802588
SANTA CLARITA, CA 913802588
Credentials & registration
- NPI registered
- August 2007 — 19 yrs on file
- Profile last updated
- November 10, 2025
- Year of graduation
- 1995 — 31 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- California #A91861
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1144412453. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,864
Distinct HCPCS
10
Medicare allowed
$188,513
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,357 | 172 | $83 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 219 | 164 | $182 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 79 | 46 | $194 | |
99291 |
Critical care, first 30-74 minutes | 74 | 11 | $222 | |
36415 |
Insertion of needle into vein for collection of blood sample | 52 | 32 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 19 | 15 | $10 | |
84443 |
Blood test, thyroid stimulating hormone (tsh) | 18 | 13 | $16 | |
83036 |
Hemoglobin a1c level | 17 | 14 | $10 | |
84439 |
Thyroxine (thyroid chemical), free | 16 | 11 | $9 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 13 | 13 | $237 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 156. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$21
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 1 | $20.92 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
335
Patients
38
Total drug cost
$154,120
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metformin Hcl | Generic | 53 | 25 | $784 |
| Ozempic (Semaglutide) | Brand | 44 | 0 | $60,186 |
| Levothyroxine Sodium | Generic | 31 | 13 | $821 |
| Humulin R U-500 (Insulin Regular, Human) | Brand | 30 | 0 | $48,184 |
| Jardiance (Empagliflozin) | Brand | 28 | 0 | $12,110 |
| Methimazole | Generic | 23 | 0 | $630 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 20 | 0 | $9,743 |
| Basaglar Kwikpen U-100 (Insulin Glargine,hum.Rec.Anlog) | Brand | 19 | 0 | $8,910 |
| Metoprolol Tartrate | Generic | 14 | 0 | $100 |
| Novolog Flexpen (Insulin Aspart) | Brand | 14 | 0 | $9,177 |